This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nickoloff, B. J. Articles by Voorhees, J. J. Search for Related Content PubMed PubMed Citation Articles by Nickoloff, B. J. Articles by Voorhees, J. J.

American Journal of Pathology, Vol 131, 12-18, Copyright © 1988 by American Society for Investigative Pathology

REGULAR ARTICLES

Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes

BJ Nickoloff, GJ Fisher, RS Mitra and JJ Voorhees
Department of Pathology, University of Michigan Medical Center, Ann Arbor 48109-0602.

To examine whether keratinocytes (KC) may be a cellular target for the action of cyclosporin A (CsA) in psoriasis and other skin diseases, the direct antiproliferative effect of CsA was examined on rapidly proliferating KCs grown on plastic in serum-free media. CsA at concentrations of 1-10 micrograms/ml directly inhibited KC proliferation over an 8-day incubation period. CsH, an immunologically inert stereoisomer, also inhibited KC proliferation at 5-10 micrograms/ml. When CsA (1 microgram/ml) was combined with gamma- interferon (gamma-IFN; 100 units/ml), there was an additive cytostatic effect on KC proliferation. The potentiating properties of gamma-IFN (100 U/ml) were additive when combined with CsA (1 microgram/ml) and synergistic at a higher concentration of CsA (5 micrograms/ml). The cytostatic effect of CsA (5 micrograms/ml) on KC proliferation was reversible after removal of the drug. Exposure of KCs to CsA resulted in numerous lipid-laden cytoplasmic vacuoles, which began to appear after 24 hours of CsA treatment. The fact that previous reports have documented 1-3 micrograms/ml of CsA and 100 U/ml of gamma-IFN in skin lesions of psoriasis patients suggests that our in vitro results were obtained with the use of physiologically relevant concentrations of these molecules. The direct antiproliferative effects by CsA on KCs suggest that both KCs and lymphocytes may be cellular targets in vivo for the mechanism of action of CsA in psoriasis.

This article has been cited by other articles:

				D. Voskas, N. Jones, P. Van Slyke, C. Sturk, W. Chang, A. Haninec, Y. O. Babichev, J. Tran, Z. Master, S. Chen, et al. A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice Am. J. Pathol., March 1, 2005; 166(3): 843 - 855. [Abstract] [Full Text] [PDF]

				G. Schneider, F. Oswald, C. Wahl, F. R. Greten, G. Adler, and R. M. Schmid Cyclosporine Inhibits Growth through the Activating Transcription Factor/cAMP-responsive Element-binding Protein Binding Site in the Cyclin D1 Promoter J. Biol. Chem., November 8, 2002; 277(46): 43599 - 43607. [Abstract] [Full Text] [PDF]